Mesoblast (MESO) FCF Margin (2016 - 2023)
Mesoblast recorded quarterly FCF Margin of 303.58% in Q2 2023, up 107.57% quarter-over-quarter from 4008.87% in Q1 2023, and up 92831.0% year-over-year from N/an in Q2 2022.
Mesoblast's FCF Margin history runs 8 years deep, the most recent figure standing at 303.58% for Q2 2023.
- In Q2 2023, FCF Margin rose 92831.0% year-over-year to 303.58%; the TTM figure through Mar 2023 stood at 802.6% (up 41459.0% YoY), while the FY2025 annual figure was 294.69%, changed N/A from the prior year.
- FCF Margin came in at 303.58% for Q2 2023 at Mesoblast, up from 4008.87% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 2033.49% in Q1 2019 to a low of 4905.64% in Q2 2019.
- A 5-year average of 776.89% and a median of 478.56% in 2022 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin jumped 457325 bps in 2020 and tumbled 314135 bps in 2022, its largest moves.
- Mesoblast's FCF Margin stood at 67.55% in 2019, then plunged by 2120 bps to 1364.57% in 2020, then jumped by 44 bps to 764.86% in 2021, then surged by 209 bps to 831.01% in 2022, then tumbled by 63 bps to 303.58% in 2023.
- According to Business Quant data, FCF Margin over the past three periods registered 303.58%, 4008.87%, and 831.01% for Q2 2023, Q1 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.17% |
| 10 | Mesoblast | 23.40 Bn | 23.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 303.58% |
| Mar 31, 2023 | -4,008.87% |
| Dec 31, 2022 | 831.01% |
| Sep 30, 2022 | 990.09% |
| Jun 30, 2022 | -624.73% |
| Mar 31, 2022 | -4,391.15% |
| Dec 31, 2021 | -764.86% |
| Sep 30, 2021 | 751.40% |
| Jun 30, 2021 | -947.90% |
| Mar 31, 2021 | -1,249.80% |
| Dec 31, 2020 | -1,364.57% |
| Sep 30, 2020 | -2,158.39% |
| Jun 30, 2020 | -332.40% |
| Mar 31, 2020 | 956.03% |
| Dec 31, 2019 | 67.55% |
| Sep 30, 2019 | 831.09% |
| Jun 30, 2019 | -4,905.64% |
| Mar 31, 2019 | 2,033.49% |
| Dec 31, 2018 | -166.72% |
| Sep 30, 2018 | 1,942.74% |
| Jun 30, 2018 | -7,637.41% |
| Mar 31, 2018 | 1,978.10% |
| Dec 31, 2017 | 941.98% |
| Sep 30, 2017 | -1,733.90% |
| Jun 30, 2017 | -4,140.46% |
| Mar 31, 2017 | -2,849.28% |
| Dec 31, 2016 | -5,897.69% |
| Sep 30, 2016 | -9,553.67% |
| Jun 30, 2016 | -67.30% |
| Mar 31, 2016 | -572.31% |